-, Apalutamide placebo, JNJ-56021927
56021927PCR3002
Phase 3 small_molecule active
Quick answer
-, Apalutamide placebo, JNJ-56021927 for Metastatic Hormone-sensitive Prostate Cancer is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Metastatic Hormone-sensitive Prostate Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active